Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LSS | P48449 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2159788 | 1.00 | CYP1A2 (0.50) | CYP1A2HTTLMNAMAPK1GNAI3 | |
| SCHEMBL17592459 | 1.00 | CYP1A2 (0.50) | CYP1A2HTTLMNAMAPK1GNAI3 | |
| SCHEMBL2404044 | 0.98 | CYP1A2 (0.48) | CYP1A2HTTLMNAMAPK1GNAI3 | |
| SCHEMBL2406734 | 0.98 | CYP1A2 (0.48) | CYP1A2HTTLMNAMAPK1GNAI3 | |
| SCHEMBL2406519 | 0.98 | CYP1A2 (0.48) | CYP1A2HTTLMNAMAPK1GNAI3 | |
| SCHEMBL25015820 | 0.98 | CYP1A2 (0.48) | CYP1A2HTTLMNAMAPK1GNAI3 | |
| SCHEMBL2405113 | 0.98 | CYP1A2 (0.48) | CYP1A2HTTLMNAMAPK1GNAI3 | |
| SCHEMBL25015819 | 0.98 | CYP1A2 (0.48) | CYP1A2HTTLMNAMAPK1GNAI3 | |
| SCHEMBL2405787 | 0.98 | CYP1A2 (0.48) | CYP1A2HTTLMNAMAPK1GNAI3 | |
| SCHEMBL24920262 | 0.98 | CYP1A2 (0.48) | CYP1A2HTTLMNAMAPK1GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170305859-A1 | An Anticonvulsant Compound | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2017-10-26 | — | — | US | claimed |
| EP-3191088-A1 | AN ANTICONVULSANT COMPOUND | Royal Holloway And Bedford New College (GB) | 2017-07-19 | — | — | EP | claimed |
| WO-2016038379-A1 | AN ANTICONVULSANT COMPOUND | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2016-03-17 | — | — | WO | claimed |
| US-20230043159-A1 | MATRIPTASE 2 INHIBITORS AND USES THEREOF | DISC MEDICINE, INC. | 2023-02-09 | — | — | US | disclosed |
| US-10301263-B2 | Anticonvulsant compound | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2019-05-28 | — | — | US | disclosed |
| US-20170305859-A1 | An Anticonvulsant Compound | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2017-10-26 | — | — | US | disclosed |
| EP-3191088-A1 | AN ANTICONVULSANT COMPOUND | Royal Holloway And Bedford New College (GB) | 2017-07-19 | — | — | EP | disclosed |
| WO-2016038379-A1 | AN ANTICONVULSANT COMPOUND | ROYAL HOLLOWAY AND BEDFORD NEW COLLEGE (GB) | 2016-03-17 | — | — | WO | disclosed |
| US-8450726-B2 | Articles containing coatings of amic acid salts | EASTMAN KODAK COMPANY (US) | 2013-05-28 | — | — | US | disclosed |
| US-8431433-B2 | Methods of providing semiconductor layers from amic acid salts | EASTMAN KODAK COMPANY (US) | 2013-04-30 | — | — | US | disclosed |
| US-8404892-B2 | Aromatic amic acid salts and compositions | EASTMAN KODAK COMPANY (US) | 2013-03-26 | — | — | US | disclosed |
| US-8212243-B2 | Organic semiconducting compositions and N-type semiconductor devices | EASTMAN KODAK COMPANY (US) | 2012-07-03 | — | — | US | disclosed |
| US-8212243-B2 | Organic semiconducting compositions and N-type semiconductor devices | EASTMAN KODAK COMPANY (US) | 2012-07-03 | — | — | US | disclosed |
| US-20110294257-A1 | METHODS OF PROVIDING SEMICONDUCTOR LAYERS FROM AMIC ACID SALTS | KODAK AMERICAS LTD. | 2011-12-01 | — | — | US | disclosed |
| US-20110295010-A1 | AROMATIC AMIC ACID SALTS AND COMPOSITIONS | FPC INC. | 2011-12-01 | — | — | US | disclosed |
| US-20110180784-A1 | ORGANIC SEMICONDUCTING COMPOSITIONS AND N-TYPE SEMICONDUCTOR DEVICES | BANK OF AMERICA, N.A., AS AGENT | 2011-07-28 | — | — | US | disclosed |
| US-20110183462-A1 | METHOD OF MAKING N-TYPE SEMICONDUCTOR DEVICES | BANK OF AMERICA, N.A., AS AGENT | 2011-07-28 | — | — | US | disclosed |
| US-20110180784-A1 | ORGANIC SEMICONDUCTING COMPOSITIONS AND N-TYPE SEMICONDUCTOR DEVICES | BANK OF AMERICA, N.A., AS AGENT | 2011-07-28 | — | — | US | disclosed |
| US-20110183462-A1 | METHOD OF MAKING N-TYPE SEMICONDUCTOR DEVICES | BANK OF AMERICA, N.A., AS AGENT | 2011-07-28 | — | — | US | disclosed |
| WO-2011090953-A1 | ORGANIC SEMICONDUCTING COMPOSITIONS AND N-TYPE SEMICONDUCTOR DEVICES | EASTMAN KODAK COMPANY (US) | 2011-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110295010-A1 | AROMATIC AMIC ACID SALTS AND COMPOSITIONS | DDC, MYOC, TNNC1 | CYP1A2 679/4885HTT 1568/4885LMNA 290/4885 |
| US-20170305859-A1 | An Anticonvulsant Compound | PSEN2, BACE2, APP | CYP1A2 279/4885HTT 453/4885LMNA 2224/4885 |
| US-20230043159-A1 | MATRIPTASE 2 INHIBITORS AND USES THEREOF | MMP7, MATR3, SPINT2 | CYP1A2 1458/4885HTT 1483/4885LMNA 1207/4885 |
| US-10301263-B2 | Anticonvulsant compound | PSEN2, BACE2, APP | CYP1A2 230/4885HTT 514/4885LMNA 2621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.